Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > VERY NICE & VERY REASSURING DATA!!

<< Previous

Bullboard Posts

Next >>

Comment by enriquesuaveon Nov 30, 2021 12:47pm

540 Views

Post# 34180865

RE:VERY NICE & VERY REASSURING DATA!!

Yes. IMO this confirm that there is Avery good chance that Efficacy will be unsurpassed and way passed Keytruda's 19% 12 months CR rate. TLD-1433 May make the competition look like placebos which have way more treatment sessions and side effects. We will hopefully win on all fronts. Efficacy, Safety, Patient comfort and morbidity, with only 2 Single Treatments Vs the competition which has from 4 to 36 treatments . All IMO do your DD

<< Previous

Bullboard Posts

Next >>

Day trading vs. swing trading strategies for small-cap stocks